Learn more

FORENDO PHARMA LTD

Overview
  • Total Patents
    50
  • GoodIP Patent Rank
    31,038
About

FORENDO PHARMA LTD has a total of 50 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are UMECRINE AB, JENAPHARM GMBH AND CO KG and NEURMEDIX INC.

Patent filings per year

Chart showing FORENDO PHARMA LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Koskimies Pasi 43
#2 Lammintausta Risto 31
#3 Eloranta Maire 27
#4 Hirvelä Leena 26
#5 Kangas Lauri 23
#6 Unkila Mikko 23
#7 Hakola Marjo 20
#8 Hirvela Leena 13
#9 Stjernschantz Camilla 12
#10 Linnanen Tero 12

Latest patents

Publication Filing date Title
WO2020115371A1 Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1
WO2018224736A2 15.beta.-[3-propanamido]-substituted estra-1,3,5(10)-trien-17-one compounds and their 17-oximes for use in inhibition of 17.beta.-hydroxysteroid dehydrogenases
CN107207562A The prodrug of 17 beta hsd 1 inhibitors
WO2016102776A1 Prodrugs of 17.beta.-hsd1 -inhibitors
CN105518016A Therapeutically active estratrienthiazole derivatives as inhibitors of 17 beta-hydroxysteroid dehydrogenase, type 1
WO2014207310A1 Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase
CN105518017A Therapeutically active estratrienthiazole derivatives as inhibitors of 17beta-hydroxy-steroid dehydrogenase, type 1
EP2518039A1 Method for the preparation of therapeutically valuable triphenylbutene derivatives